Trial of Cyclosporine in the Acute Phase of Leber Hereditary Optic Neuropathy
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The Leber Hereditary Optic Neuropathy is a genetic disorder caused by maternal transmission
of mitochondrial DesoxiroboNucleid Acid mutations. It is manifested by a rapidly progressive
blindness, profound, due to atrophic optic nerve. The visual loss is primarily unilateral
bilateralisation taking place in the vast majority of cases in weeks or months. The
neuro-cardio-protective properties of cyclosporine (and its analogs specifically targeting
the anti-apoptotic mechanisms) are particularly promising.
The investigators hypothesis is that cyclosporine may limit apoptosis during the acute phase
of the disease process and would limit the loss of visual acuity and improve the visual
prognosis of these patients.